Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M24,681Revenue $M9,023Net Margin (%)9.4Altman Z-Score2.3
Enterprise Value $M30,509EPS $1.8Operating Margin %15.0Piotroski F-Score7
P/E(ttm)28.6Beneish M-Score-2.0Pre-tax Margin (%)10.1Higher ROA y-yN
Price/Book2.510-y EBITDA Growth Rate %12.4Quick Ratio1.2Cash flow > EarningsY
Price/Sales2.65-y EBITDA Growth Rate %8.3Current Ratio1.8Lower Leverage y-yY
Price/Free Cash Flow39.2y-y EBITDA Growth Rate %-2.9ROA % (ttm)3.4Higher Current Ratio y-yY
Dividend Yield %--PEG3.5ROE % (ttm)9.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M492ROIC % (ttm)6.6Gross Margin Increase y-yY

Gurus Latest Trades with MYL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYLVanguard Health Care Fund 2015-12-31 Add0.11%$39.16 - $55.28
($48.35)
$ 50.745%Add 4.26%24,253,075
MYLMario Gabelli 2015-12-31 Reduce-0.01%$39.16 - $55.28
($48.35)
$ 50.745%Reduce -60.67%26,450
MYLDavid Tepper 2015-09-30 Reduce-0.87%$39.8 - $71.49
($55.75)
$ 50.74-9%Reduce -52.50%470,071
MYLVanguard Health Care Fund 2015-09-30 Add0.64%$39.8 - $71.49
($55.75)
$ 50.74-9%Add 46.38%23,262,875
MYLJohn Keeley 2015-09-30 Add0.02%$39.8 - $71.49
($55.75)
$ 50.74-9%Add 51.47%56,120
MYLMario Gabelli 2015-09-30 Add0.01%$39.8 - $71.49
($55.75)
$ 50.74-9%Add 102.26%67,250
MYLJohn Paulson 2015-06-30 Add2.24%$57.94 - $76.06
($70.49)
$ 50.74-28%Add 46.59%21,913,061
MYLDavid Tepper 2015-06-30 Buy 1.66%$57.94 - $76.06
($70.49)
$ 50.74-28%New holding989,528
MYLFirst Eagle Investment 2015-06-30 Sold Out -0.08%$57.94 - $76.06
($70.49)
$ 50.74-28%Sold Out0
MYLJohn Keeley 2015-06-30 Buy 0.06%$57.94 - $76.06
($70.49)
$ 50.74-28%New holding37,050
MYLJoel Greenblatt 2015-06-30 Sold Out -0.01%$57.94 - $76.06
($70.49)
$ 50.74-28%Sold Out0
MYLMario Gabelli 2015-06-30 Add0.01%$57.94 - $76.06
($70.49)
$ 50.74-28%Add 232.50%33,250
MYLJoel Greenblatt 2015-03-31 Reduce-0.3%$52.74 - $64.96
($57.01)
$ 50.74-11%Reduce -97.62%16,021
MYLVanguard Health Care Fund 2015-03-31 Add0.11%$52.74 - $64.96
($57.01)
$ 50.74-11%Add 5.68%15,891,898
MYLFirst Eagle Investment 2015-03-31 Reduce-0.04%$52.74 - $64.96
($57.01)
$ 50.74-11%Reduce -30.38%586,016
MYLJohn Paulson 2014-12-31 Add0.72%$46.5 - $58.62
($53.92)
$ 50.74-6%Add 19.64%14,948,400
MYLJoel Greenblatt 2014-12-31 Buy 0.31%$46.5 - $58.62
($53.92)
$ 50.74-6%New holding673,287
MYLVanguard Health Care Fund 2014-12-31 Reduce-0.05%$46.5 - $58.62
($53.83)
$ 50.74-6%Reduce -2.64%15,037,080
MYLFirst Eagle Investment 2014-12-31 Add$46.5 - $58.62
($53.83)
$ 50.74-6%Add 3.97%841,779
MYLVanguard Health Care Fund 2014-09-30 Add1.24%$44.97 - $52.34
($48.56)
$ 50.744%Add 223.41%15,444,880
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MYL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SHEEHAN JOHN DEVP and CFO 2015-12-17Sell34,579$55.03-7.8view
HIGGINS MELINA EDirector 2015-06-15Sell8,351$73.08-30.57view
Cindrich Robert JDirector 2015-02-03Sell40,645$53.15-4.53view
CAMERON WENDYDirector 2015-02-03Sell106,551$53.15-4.53view
COURY ROBERT JExecutive Chairman 2015-02-03Sell947,119$52.55-3.44view
Malik RajivPresident 2015-02-03Sell285,394$53.15-4.53view
MAROON JOSEPH C MDDirector 2015-02-03Sell136,551$53.15-4.53view
BRESCH HEATHER MCEO 2015-02-03Sell411,996$53.15-4.53view
DIMICK NEIL FDirector 2015-02-03Sell19,781$53.15-4.53view
Mauro AnthonyPresident, North America 2015-02-03Sell13,255$53.15-4.53view

Press Releases about MYL :

Quarterly/Annual Reports about MYL:

    News about MYL:

    Articles On GuruFocus.com
    Keeley Funds Comments on Mylan N.V. Feb 03 2016 
    KEELEY All Cap Value Fund Commentary - 4th Quarter 2015 Feb 03 2016 
    David Einhorn Comments on Mylan Jan 19 2016 
    Glenview's Larry Robbins Lowers Drug Manufacturers, Raises Providers Nov 20 2015 
    Health Care Investor Larry Robbins Lowers Drug Manufacturers, Raises Providers Nov 20 2015 
    John Paulson Keeps Gold, Buys Drug Manufacturers Nov 17 2015 
    Vanguard Raises Stakes in Biogen, Mylan, Merck Nov 15 2015 
    Keeley Funds Comments on Mylan NV Nov 03 2015 
    Vanguard Health Care Fund Buys Biogen and Mylan, Cuts Pfizer Nov 02 2015 
    Alan Fournier Sells Nine Stakes in Second Quarter Sep 12 2015 

    More From Other Websites
    What to Watch in the Day Ahead - Wednesday, Feb 10 Feb 09 2016
    Mylan And Teva Earnings Are Coming: Here's What To Expect Feb 08 2016
    Mylan (MYL) to Report Q4 Earnings: What's in the Cards? Feb 08 2016
    Perrigo’s Shareholders Rejected Mylan’s Offer on Value Dilution Feb 08 2016
    Mylan NV breached its 50 day moving average in a Bearish Manner : February 8, 2016 Feb 08 2016
    The Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, United Therapeutics and INSYS... Feb 03 2016
    4 Top-Ranked Biotech Stocks on Sale Feb 02 2016
    Stock Watchout on Drugs - Generic -- Mylan, Neurocrine Biosciences, Horizon Pharma, and Zoetis Feb 02 2016
    Mylan’s PE Ratio of 10.1x Is Lower Than Its Peer Ratios Feb 01 2016
    [$$] Barron's 2016 Roundtable, Part 3: 12 Stock Picks Jan 30 2016
    The Majority of Brokers Recommend a “Buy” for Mylan Jan 28 2016
    Analysts Expect Mylan’s Growth to Be at 29.7% for 4Q15 Jan 28 2016
    Mylan NV breached its 50 day moving average in a Bullish Manner : January 25, 2016 Jan 25 2016
    [$$] Part 2 of the Barron's 2016 Roundtable: 31 Savvy Investment Ideas Jan 23 2016
    Mylan to Report Fourth Quarter and Full Year 2015 Financial Results on Feb. 10, 2016 Jan 21 2016
    David Einhorn Feels Mylan's Pain Jan 20 2016
    David Einhorn and the Terrible, Horrible, No Good, Very Bad 2015 Jan 20 2016
    David Einhorn's New Long Position In Mylan Jan 19 2016
    Highlights From Greenlight’s Q4 Letter: Micron Is Out & Two New Positions Jan 19 2016
    A Look Into David Einhorn's Q4 Letter To Greenlight Investors Jan 19 2016
    Mylan Launches Generic Felbatol® Tablets Jan 19 2016
    U.S. copy of GSK's Advair a step closer as Mylan files generic version Jan 12 2016
    2016 Jan 06 Phosphagenics Initiates Arbitration Against Mylan Jan 06 2016
    Phosphagenics Initiates Arbitration against Mylan Jan 06 2016
    Mylan Appoints Ranjan Ray Chaudhuri as Global Commercial Lead for Mylan's Over-the-Counter Business Nov 24 2015
    Mylan Third Quarter 2015 Constant Currency Adjusted Total Revenues Increase 36% and Adjusted Diluted... Nov 23 2015
    U.S. District Court Denies Perrigo's Motion for Preliminary Injunction Related to Certain Mylan... Nov 20 2015
    Mylan Confirms Availability of EpiPen® (epinephrine injection) Auto-Injector for U.S. Patients... Nov 19 2015
    Tel Aviv District Court Rules in Favor of Mylan Listing on Tel Aviv Stock Exchange Nov 19 2015
    US STOCKS-U.S. stocks fall, with retail, technology leading rout Nov 13 2015
    Big deal momentum may carry into 2016 for health care Nov 13 2015
    Mylan's $35 bn bid for Perrigo fails Nov 13 2015
    Perrigo to go it alone; shareholders reject $26B Mylan bid Nov 13 2015
    Perrigo tumbles as shareholders reject Mylan offer Nov 13 2015
    Shareholders of drugmaker Perrigo shut the door on Mylan and its $26B, hostile takeover bid Nov 13 2015
    Mylan's $35 bn bid for Perrigo fails Nov 13 2015
    Mylan's tender offer for Perrigo unlikely to succeed - sources Nov 12 2015
    Mylan-targeted Perrigo held merger talks with Endo - sources Nov 12 2015
    Perrigo Reaffirms Views on Mylan's Inadequate Offer; Maintains Strong Recommendation Shareholders... Nov 10 2015
    Perrigo Issues Shareholder Letter Nov 09 2015
    Cabinet okays $750 mn investment by Dutch drug major Nov 05 2015
    Mylan not relying on acquisitions if Perrigo bid fails -chairman Nov 04 2015
    FTC approves Mylan's hostile bid for Perrigo with conditions Nov 03 2015
    FTC clears Mylan's $27B proposed takeover of Perrigo Nov 03 2015
    FTC approves Mylan's hostile bid for Perrigo with conditions Nov 03 2015
    FTC approves hostile Mylan takeover of Perrigo with conditions Nov 03 2015
    Perrigo Comments On Mylan's Presentation Oct 30 2015
    Mylan profit beats as generic sales jump in North America and Europe Oct 30 2015
    Mylan beats 3Q profit forecasts Oct 30 2015
    U.S. FDA warns Novartis on manufacturing violations at two India plants Oct 28 2015
    Perrigo CEO doesn't believe Mylan's hostile bid will succeed Oct 27 2015
    Perrigo Taking Actions To Deliver Shareholder Value Far Superior To Mylan Offer Oct 22 2015
    Irish takeover panel rejects Perrigo's request over Mylan offer Oct 13 2015
    Paragraph IV Notice from Mylan Technologies Inc... Oct 05 2015
    Exclusive - Perrigo under shareholder pressure to explore sale: sources Sep 29 2015
    Perrigo urges shareholders to reject Mylan takeover offer Sep 17 2015
    Perrigo Board Unanimously Rejects Mylan's Unsolicited Exchange Offer As Inadequate Sep 17 2015
    Mylan opens $27.14 billion hostile bid for Perrigo Sep 15 2015
    Mylan takes takeover bid to Perrigo shareholders Sep 14 2015
    Mylan Statement in Response to FDA Warning Letter Relating to Certain Agila Facilities Sep 14 2015
    Perrigo Announcement Regarding Unsolicited Offer From Mylan N.V. Sep 14 2015
    Theravance Biopharma and Mylan Initiate Phase 3 Program for Revefenacin (TD-4208) for Treatment of... Sep 14 2015
    Perrigo Responds to Misleading Letter from Mylan Executive Chairman Sep 10 2015
    Mylan says it will launch $27.14B bid for Perrigo Sep 08 2015
    Mylan takes takeover bid to Perrigo shareholders Sep 08 2015
    Mylan and Disney Team Up to Bring New Resources to Life for Families Managing Potentially... Sep 08 2015
    Egan-Jones Joins Glass Lewis in Recommending Mylan Shareholders Vote For Perrigo Transaction... Sep 08 2015
    Largest Dutch pension fund exits Mylan over death penalty concerns Aug 29 2015
    Mylan shareholders approve hostile takeover Aug 28 2015
    Mylan shareholders approve pursuit of Perrigo Aug 28 2015
    Mylan lowers shareholder acceptance bar on Perrigo offer Aug 13 2015
    Mylan beats 2Q profit forecasts Aug 06 2015
    Mylan gets EU clearance for Perrigo clearance Jul 29 2015
    Mylan gets European clearance in proposed Perrigo takeover Jul 29 2015
    Hikma to buy Boehringer's U.S. generic drug business for $2.65 bln Jul 28 2015
    Teva to buy Allergan generic business for $40.5 bln, drops Mylan bid Jul 27 2015
    Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid Jul 27 2015
    Teva to buy Allergan generic drug unit for $40.5 bn Jul 27 2015
    Botox owner Allergan sells generic drugs unit to Teva for $41bn Jul 27 2015
    Botox owner Allergan in talks to sell generic drugs unit to Teva for $45bn Jul 27 2015
    Mylan foundation to block Israel's Teva hostile takeover bid Jul 23 2015
    Teva to lift bid for Mylan: report Jul 06 2015
    Exclusive - Teva poised to raise its stake in Mylan -sources Jun 02 2015
    Teva increases pressure on $40bn takeover target Mylan May 27 2015
    Generic drugmaker Teva makes $40 billion offer for rival Mylan Apr 21 2015
    Top Mylan shareholders seek deal with Teva - sources Apr 21 2015
    Exclusive - Perrigo expected to reject Mylan offer as soon as this week: source Apr 21 2015
    Mylan plans $5-bn investment in Andhra Pradesh Apr 20 2015
    Mylan plans $5 bn investment in Andhra Pradesh Apr 20 2015
    Mylan settles Viagra patent litigation with Pfizer Apr 13 2015
    Generic drugmaker Mylan offers $29 billion for Perrigo Apr 08 2015
    Corrected - UK says Mylan recalls batches of Polish-made antibiotic Jun 19 2014
    UK says Mylan recalls batches of Indian-made antibiotic Jun 18 2014

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK